Delhi Suspends Record 235 Pharmacy Licenses Amid Crackdown on Fake Registrations
AI-Generated Summary
Delhi authorities suspended a record 235 pharmacy licenses in the financial year 2024-25, alongside 14 cancellations, marking a significant increase in enforcement. This action targets a long-standing concern of fake registrations and non-compliance in the pharmaceutical sector. Officials attribute the higher numbers to increased vigilance and a recent boost in drug inspector recruitment, aiming to mitigate public health risks posed by unauthorized operations.
In a nutshell
This surge in license suspensions reflects a proactive and much-needed crackdown on illicit pharmaceutical operations in Delhi, driven by enhanced regulatory oversight. While the numbers appear high, officials emphasize it signifies improved vigilance and enforcement rather than an escalation of the problem, ultimately safeguarding public health.
Source: Hindustan Times
